Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Renub Research | PRODUCT CODE: 1965748

Cover Image

PUBLISHER: Renub Research | PRODUCT CODE: 1965748

High Intensity Focused Ultrasound (HIFU) Market Report by Imaging Technology, Application, End User, CountriesCountries and Company 2026-2034

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3490
PDF (5 User License + Excel)
USD 3990
PDF (Corporate License)
USD 4490

Add to Cart

High-Intensity Ultrasound Therapy Market Size and Forecast 2026-2034

The high-intensity ultrasound therapy market is estimated to exhibit constant growth over time, and this growth will increase throughout the forecast period owing to factors such as increasing acceptance of non-invasive and minimally invasive treatments, rising incidence of chronic diseases, and development of new ultrasound-based technologies used in the field of medicine. In addition, customers are increasingly seeking precision treatments for diseases such as cancer, pain, and cosmetics, thereby also propelling the growth of the high-intensity ultrasound therapy market, which will rise from its current figure of US$128.53 Billion in 2025 to reach US$ 251.21 Billion in 2034, growing at a CAGR of 7.73% from 2026 to 2034 owing to the acceptance of high-intensity ultrasound therapy solutions worldwide.

High Intensity Ultrasound Therapy Market Overview

High-intensity ultrasound treatment is a non-invasive medical treatment technique wherein high-intensity ultrasound waves are focused and directed toward the affected tissues with abnormal cell growth. Such ultrasound treatment completely destroys the abnormal tissues and encourages healthy cell growth. Normally, this is used for tumor therapy, pain management, physiotherapy, uterine fibroid therapy, and cosmetic treatments like skin tightening and fat reduction. This form of therapy has minimized risk because no surgical incision is required for its application, it doesn't involve radiation, and recovery is fast with reduced complications.

The huge demand for non-invasive and patient-centric treatment approaches all over the world has helped the high-intensity ultrasound therapy find its place as an extremely popular form of therapy. Increased awareness about the latest technology-based treatments, in addition to the rise in the incidence of various chronic health conditions and improvements in the process of ultrasound imaging and targeting, has enhanced the adoption process immensely. There is an obvious shift on the part of both patients and healthcare providers toward therapy options ensuring increased precision, safety, and faster recovery. Hence, high-intensity ultrasound therapy has started to become an alternative to traditional surgeries and invasive treatments in different parts of the world as an effort to keep evolving in the field of technology.

Growth Driver of the High Intensity Ultrasound Therapy Market

Growing Demand for Non-Invasive and Minimally Invasive Treatments

The reason high-intensity ultrasound therapy makes the treatment option so perfect is the combination of what the treatment modality offers for oncological treatments, pain treatments, physiotherapies, and cosmetic treatments without the need for surgery, anesthesia, or the need for exposure to the risks of radiation. The reduced cost of hospitalization and the need for reduced downtime in returning to normal activities will only make the option of ultrasound therapy and treatments more popular in the future. The need for ultrasound therapy will continue to rise and gain momentum as several health care programs streamline the basic requirements of ensuring patient safety, overall patient comfort, and cost efficacy. April 2025-EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced the release of its new "Focal One i." Improved HIFU fusion technology to include Prostate Specific Membrane Antigen PET scans, ExactVu MicroUltrasound, Unfold AI, OnQ Prostate, additional capabilities in Koelis 3D Biopsy Maps,

Rising Prevalence of Chronic Diseases and Cancer

The forecasted incidence of new cancer cases is over 35 million by 2050, representing a 77% increase compared to the forecast of 20 million cases of cancer in 2022. The rise in cancer incidence and the increasingly aging and growing population is a result of changes in the population's exposure to cancer risk factors, some of which are associated with socioeconomic development. The rise in global incidence of chronic and cancer diseases is greatly contributing to the increasing requirement for high-intensity ultrasound therapy. Cancer, musculoskeletal disorders, uterine fibroids, and painful conditions require effective and precise treatments. Ultrasound treatment with high heat intensity provides effective and precise treatments with minimal damage to healthy tissues. This is advantageous because cancer and other complex treatments can be carried out on the affected points without damaging them or the healthy tissues. In addition, cancer incidence and aging contribute to the increase in market size due to early detection of cancer and the availability of more effective treatments.

Technological Advancements and Improved Treatment Precision

Continuous technological advancements have led to an improvement in the effectiveness and viability of the systems utilized in high-intensity ultrasound therapy. This improvement in relation to the integration, monitoring, as well as focusing of high-intensity ultrasound, has significantly enhanced the accuracy and safety of such methods. Advanced systems offer a way in which an individual, through visualization, can target the use of energy, thus preventing side effects. The compact design of these systems offers extensive applications in various settings. This evolving technology in high-intensity ultrasound therapy ensures it is becoming versatile, reliable, and thus contributes to the continuously improving market. Sept 2025 - UC Davis Comprehensive Cancer Center completed its 100th robotic high-intensity focused ultrasound, or HIFU, procedure for treating men with prostate cancer.

Key Challenges of the High-Intensity Ultrasound Therapy Market

High Equipment Cost and Limited Accessibility

The high cost of the equipment is considered to be one of the major challenges that are faced in the high-intensity ultrasound therapy market. Advanced ultrasound therapy equipment requires high-level imaging integration, precise targeting technology, etc., all of which play a major role in adding up to the cost of equipment purchase as well as installation. Therefore, high cost can only be afforded in large settings of hospitals; thus, it creates an entry barrier for high-intensity ultrasound therapy machines. Although reimbursement in some of the regions may not completely discourage the purchase of the medical equipment, still it is a warning signal that suggests investment in this equipment is not a good idea.

Limited Clinical Awareness and Skilled Workforce Availability

Some other significant challenges, which may hamper the growth of the high-intensity ultrasound therapy market, relate to low levels of clinical awareness and a lack of skilled operators. Even though the high-intensity ultrasound therapy option possesses a number of benefits, there is still less awareness, either on the part of the patients or practitioners, regarding its effectiveness when compared with other conventional therapeutic methods. This is one of the areas where training is required for the appropriate utilization of the high-intensity ultrasound therapy option. It is important to ensure appropriate patient targeting and safety for the therapy to be effective. Any deficit found in this regard would relate to a possible limitation in the usage of this option, which could pose dangers to the patient too. There is a need to expand training and awareness building programs to deal with this issue effectively.

MRI HIFU Therapy Market

The MRI HIFU therapy market is increasing due to the ability of the device to handle the simultaneous use of high-intensity ultrasounds and images, which are required for monitoring the therapy. This device is mostly used in the treatment of uterine fibroids, prostate cancer, bone metastases, and neurological disorders. Therefore, it is clear that the acceptance of the need for the device due to the requirement of non-invasive and non-radiation therapy is greatly impacting the growth of the MRI HIFU therapy device market. The improvement of MRI-compatible ultrasound devices and the emergence of scientific evidence are also supporting the MRI HIFU device market. Therefore, precision medicine is becoming more important, and MRI HIFU therapy device usage is gaining more recognition, especially in advanced medical centers worldwide.

HIFU Prostate Cancer Therapy Market

Such areas as the HIFU prostate cancer therapy market are influenced by several key areas, for instance, the rising demand for effective and least intrusive therapy options for the treatment of prostate cancer. HIFU offers precise tissue destruction of affected cells in the prostate gland using minimal damage to structures such as nerves and bladder. Consequently, it helps in reducing complications such as incontinence and impotence. This is due to the aging population and the rise in prostate cancer cases. Due to the current and rising cases of prostate cancer in the population and the rise in population ages, HIFU therapy is on the rise in terms of therapy value.

HIFU Neurological Disorders Therapy Market

The market size of HIFU therapy for neurological disorders is increasing due to the possibility of treating neurological disorders without any surgical invasion. MRI-guided HIFU can treat essential tremor, Parkinson's, and other types of movement disorders by precisely targeting the specific part of the brain where the disorder has occurred. HIFU has the ability to treat many different types of neurological disorders, though many aspects of neurological treatments are untapped. As more research goes into treating various types of neurological disorders, it is important to note that the HIFU therapy could not be ignored in the progress of neurological treatments.

High-Intensity Ultrasound Therapy Diagnostic Centers Market

The market potential of diagnostic centers for providing high-intensity ultrasound therapy is also on the increase as these centers are increasingly adopting high-tech facilities for giving ultrasound therapy treatment to their patients. Diagnostic and specialty clinics are providing expert health care facilities in treatment, which are also cost-effective. Further, health facilities that are planned for decentralization also generate demand for ultrasound therapy treatments, thereby playing a crucial role in providing high-intensity ultrasound therapy treatments to patients worldwide.

United States High-Intensity Ultrasound Therapy Market

The USA represents one of the most technologically advanced markets in the world, considering the prevailing strong infrastructural facilities of health care and the adoption of innovative medical technologies at the right time. The high prevalence of chronic diseases, cancer, and musculoskeletal disorders is contributing to the demand for high-intensity ultrasound therapy solutions. Apart from the positive factors, many of the top-grade hospitals and health care facilities are adopting and utilizing the cutting-edge MRI-guided technology in the field of HIFU for oncology and neurology cases. The favorable conditions for research funding and clinical trial activities are also positive factors supporting the HIFU market in the USA. The USA is one of the promising countries contributing to the development of high-intensity ultrasound therapy technology. March 2024 - Pure Tone Aesthetics, a company known for delivering the latest innovations in medical and skincare solutions, is pleased to announce the release of its latest breakthrough product in the medical arena: Pure Tone Aesthetics Inofus HIFU Machines.

United Kingdom High-Intensity Ultrasound Therapy Market

The high-intensity ultrasound therapy market in the UK is growing rapidly due to government investments in cutting-edge technology in the field of medicine. In addition, the National Health Service provides non-invasive solutions with cost advantages for treating and caring for patients. In turn, high-intensity ultrasound therapy solutions are gaining momentum. In the context of the overall market for high-intensity ultrasound therapy solutions, this therapy has gained popularity as an effective solution for treating oncological, neurological conditions, pain management therapies, and conducting clinical trials. Whereas the solution for high-intensity therapy has been limited in terms of the extent of the treatment centers offering the therapy, the level of awareness regarding the therapy ensures ample prospects for the future. June 2025, Cleveland Clinic London has become the first facility in England to bring the solution of the robot with respect to the treatment of prostate cancers. It uses the accurate robot for targeting the affected cell.

India High-Intensity Ultrasound Therapy Market

The High Intensity Ultrasound Market is growing in India. High-intensity ultrasound therapy is becoming prominent because of growing awareness of the importance of health care and of the need for non-invasive therapy. There is also an increase in demand for high-end equipment intended for therapeutic purposes because of the incidence of cancer and many other chronic diseases. Private chains of hospitals and the need for medical tourism are also driving the high-intensity ultrasound therapy market. Kokilaben Dhirubhai Ambani Hospital, situated in India, has adopted the new High Intensity Focused Ultrasound Technology or HIFU for treating prostate cancer in January 2024. High-intensity ultrasound therapy kills the patient's cell groups using high-frequency sound waves. High-intensity ultrasound technology gives a non-invasive solution for the destruction of cancerous cell groups in the prostate gland.

Saudi Arabia High-Intensity Ultrasound Therapy Market

The market size is increasing for high-intensity ultrasonic therapy devices in Saudi Arabia, aiming to modernize health care systems in line with the Vision 2030 strategy. The rise of chronic health conditions, coupled with government spending on advanced and sophisticated devices, is unlocking market opportunities in the segment. The addition of a non-invasive health care option is contributing to the expansion of the market. January 2024, GE HealthCare had announced a comprehensive range of Imaging, Ultrasound, and Patient Care Solutions to Dr. Sulaiman Al-Habib Medical Group in Saudi Arabia to enhance clinical outcomes and deliver high-quality, seamless, and optimized patient care. GE HealthCare had partnered with HMG, one of the biggest and fastest-growing health care groups in the region, which operates thirteen hospitals and eight health care centers, including two newly launched state-of-the-art health care facilities.

Market Segmentation

Imaging Technology

  • Ultrasound HIFU Therapy
  • MRI HIFU Therapy

Application

  • Prostate Cancer
  • Uterine Fibroids
  • Neurological Disorders
  • Aesthetics
  • Others

End-User

  • Diagnostic Centers
  • Hospitals
  • Research Centers
  • Others

Regional Insights

North America

  • United States
  • Canada

Europe

  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Belgium
  • Netherlands
  • Turkey

Asia - Pacific

  • China
  • Japan
  • India
  • South Korea
  • Thailand
  • Malaysia
  • Indonesia
  • Australia
  • New Zealand

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East & Africa

  • Saudi Arabia
  • UAE
  • South Africa

All companies have been covered from 5 viewpoints:

  • Overviews
  • Key Person
  • Recent Developments
  • SWOT Analysis
  • Revenue Analysis

Company Analysis:

  • Koninklijke Philips N.V.
  • Johnson & Johnson
  • Hitachi Ltd.
  • General Electrics
  • Medtronic Plc.
  • Stryker
  • EDAP TMS S.A,
  • Theraclion

Table of Contents

1. Introduction

2. Research & Methodology

  • 2.1 Data Source
    • 2.1.1 Primary Sources
    • 2.1.2 Secondary Sources
  • 2.2 Research Approach
    • 2.2.1 Top-Down Approach
    • 2.2.2 Bottom-Up Approach
  • 2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global High Intensity Focused Ultrasound (HIFU) Market

  • 5.1 Historical Market
  • 5.2 Market Forecast

6. Market Share Analysis

  • 6.1 By Imaging Technology
  • 6.2 By Application
  • 6.3 By End User
  • 6.4 By Countries

7. Imaging Technology

  • 7.1 Ultrasound HIFU Therapy
    • 7.1.1 Historical Market
    • 7.1.2 Market Forecast
  • 7.2 MRI HIFU Therapy
    • 7.2.1 Historical Market
    • 7.2.2 Market Forecast

8. Application

  • 8.1 Prostate Cancer
    • 8.1.1 Historical Market
    • 8.1.2 Market Forecast
  • 8.2 Uterine Fibroids
    • 8.2.1 Historical Market
    • 8.2.2 Market Forecast
  • 8.3 Neurological Disorders
    • 8.3.1 Historical Market
    • 8.3.2 Market Forecast
  • 8.4 Aesthetics
    • 8.4.1 Historical Market
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Historical Market
    • 8.5.2 Market Forecast

9. End User

  • 9.1 Diagnostic Centers
    • 9.1.1 Historical Market
    • 9.1.2 Market Forecast
  • 9.2 Hospitals
    • 9.2.1 Historical Market
    • 9.2.2 Market Forecast
  • 9.3 Research Centers
    • 9.3.1 Historical Market
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Historical Market
    • 9.4.2 Market Forecast

10. Countries

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Historical Market
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Historical Market
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 France
      • 10.2.1.1 Historical Market
      • 10.2.1.2 Market Forecast
    • 10.2.2 Germany
      • 10.2.2.1 Historical Market
      • 10.2.2.2 Market Forecast
    • 10.2.3 Italy
      • 10.2.3.1 Historical Market
      • 10.2.3.2 Market Forecast
    • 10.2.4 Spain
      • 10.2.4.1 Historical Market
      • 10.2.4.2 Market Forecast
    • 10.2.5 United Kingdom
      • 10.2.5.1 Historical Market
      • 10.2.5.2 Market Forecast
    • 10.2.6 Belgium
      • 10.2.6.1 Historical Market
      • 10.2.6.2 Market Forecast
    • 10.2.7 Netherlands
      • 10.2.7.1 Historical Market
      • 10.2.7.2 Market Forecast
    • 10.2.8 Turkey
      • 10.2.8.1 Historical Market
      • 10.2.8.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 China
      • 10.3.1.1 Historical Market
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Historical Market
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Historical Market
      • 10.3.3.2 Market Forecast
    • 10.3.4 Australia
      • 10.3.4.1 Historical Market
      • 10.3.4.2 Market Forecast
    • 10.3.5 South Korea
      • 10.3.5.1 Historical Market
      • 10.3.5.2 Market Forecast
    • 10.3.6 Thailand
      • 10.3.6.1 Historical Market
      • 10.3.6.2 Market Forecast
    • 10.3.7 Malaysia
      • 10.3.7.1 Historical Market
      • 10.3.7.2 Market Forecast
    • 10.3.8 Indonesia
      • 10.3.8.1 Historical Market
      • 10.3.8.2 Market Forecast
    • 10.3.9 New Zealand
      • 10.3.9.1 Historical Market
      • 10.3.9.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Historical Market
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Historical Market
      • 10.4.2.2 Market Forecast
    • 10.4.3 Argentina
      • 10.4.3.1 Historical Market
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East & Africa
    • 10.5.1 South Africa
      • 10.5.1.1 Historical Market
      • 10.5.1.2 Market Forecast
    • 10.5.2 Saudi Arabia
      • 10.5.2.1 Historical Market
      • 10.5.2.2 Market Forecast
    • 10.5.3 UAE
      • 10.5.3.1 Historical Market
      • 10.5.3.2 Market Forecast

11. Porter's Five Forces Analysis

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Competition
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threats

13. Key Players Analysis

  • 13.1 Koninklijke Philips N.V.
    • 13.1.1 Overviews
    • 13.1.2 Key Person
    • 13.1.3 Recent Developments
    • 13.1.4 SWOT Analysis
    • 13.1.5 Revenue Analysis
  • 13.2 Johnson & Johnson
    • 13.2.1 Overviews
    • 13.2.2 Key Person
    • 13.2.3 Recent Developments
    • 13.2.4 SWOT Analysis
    • 13.2.5 Revenue Analysis
  • 13.3 Hitachi Ltd.
    • 13.3.1 Overviews
    • 13.3.2 Key Person
    • 13.3.3 Recent Developments
    • 13.3.4 SWOT Analysis
    • 13.3.5 Revenue Analysis
  • 13.4 General Electrics
    • 13.4.1 Overviews
    • 13.4.2 Key Person
    • 13.4.3 Recent Developments
    • 13.4.4 SWOT Analysis
    • 13.4.5 Revenue Analysis
  • 13.5 Medtronic Plc.
    • 13.5.1 Overviews
    • 13.5.2 Key Person
    • 13.5.3 Recent Developments
    • 13.5.4 SWOT Analysis
    • 13.5.5 Revenue Analysis
  • 13.6 Stryker
    • 13.6.1 Overviews
    • 13.6.2 Key Person
    • 13.6.3 Recent Developments
    • 13.6.4 SWOT Analysis
    • 13.6.5 Revenue Analysis
  • 13.7 EDAP TMS S.A
    • 13.7.1 Overviews
    • 13.7.2 Key Person
    • 13.7.3 Recent Developments
    • 13.7.4 SWOT Analysis
    • 13.7.5 Revenue Analysis
  • 13.8 Theraclion
    • 13.8.1 Overviews
    • 13.8.2 Key Person
    • 13.8.3 Recent Developments
    • 13.8.4 SWOT Analysis
    • 13.8.5 Revenue Analysis
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!